TABLE 2.
Group | Phentermine
|
New antiobesity pharmacotherapies
|
SGLT2s
|
||||||
---|---|---|---|---|---|---|---|---|---|
A | B | C | A | B | C | A | B | C | |
Prescribers in Xponent™ | 19% | 100% | 100% | 12% | 100% | 100% | 11% | 100% | 100% |
Active physicians in the U.S. | 16% | 74% | 81% | 10% | 76% | 86% | 9% | 70% | 83% |
Primary specialty | |||||||||
Family Medicine/General Practice | 48% | 30% | 42% | 32% | 34% | 34% | 32% | 34% | 33% |
Internal Medicine | 27% | 18% | 19% | 21% | 22% | 27% | 22% | 24% | 25% |
Endocrinology | 37% | 1% | 2% | 47% | 3% | 13% | 64% | 4% | 22% |
Obstetrics/Gynecology | 25% | 6% | 7% | 12% | 5% | 4% | |||
Psychiatry | 10% | 2% | 1% | 4% | 2% | 1% | |||
Emergency Medicine | 8% | 2% | 1% | 2% | 1% | <1% | 2% | 1% | <1% |
General Surgery | 11% | 2% | 2% | 4% | 1% | 1% | |||
Cardiovascular Diseases | 7% | 1% | 1% | 5% | 1% | <1% | |||
Internal Medicine/Pediatrics | 14% | 1% | <1% | ||||||
Geriatric Medicine | 13% | 1% | <1% | ||||||
Pediatrics | 4% | 1% | 1% | ||||||
Nephrology | 4% | <1% | <1% | ||||||
Unavailable | N/A | 2% | <1% | N/A | 2% | <1% | N/A | 10% | 3% |
Physicians by region | |||||||||
South | 20% | 43% | 46% | 13% | 44% | 46% | 11% | 42% | 41% |
Midwest | 16% | 22% | 16% | 10% | 21% | 16% | 9% | 22% | 16% |
West | 14% | 20% | 10% | 8% | 17% | 11% | 6% | 16% | 13% |
Northeast | 10% | 14% | 7% | 7% | 17% | 12% | 7% | 19% | 12% |
Pacific | 12% | 1% | <1% | 7% | <1% | <1% | 8% | 1% | <1% |
Unavailable | N/A | <1% | <1% | N/A | <1% | <1% | N/A | <1% | <1% |
Prescriber-drug overlap | |||||||||
Phentermine | 69% | 57% | |||||||
New antiobesity pharmacotherapies | 41% | 51% | |||||||
SGLT2s | 33% | 50% |
Prescriber-drug overlap represents the percentage of prescribers of the column drug category who also prescribed the row drug category.
A: % of group who prescribed drug(s) = drug prescribers from group/active physicians in group. B: % of drug prescribers from group = drug prescribers from group/all prescribers of drug(s). C: % of drug prescriptions in the U.S. from group = drug prescriptions from group/all prescriptions of drug(s). Specialties reported represent the top eight most frequent prescribing specialties per drug category.